Progress and prospects: genetic engineering in xenotransplantation.

Area of Science:

• Biomedical Engineering
• Immunology
• Transplantation Science

Background:

• Xenotransplantation offers a potential solution to organ shortages.
• Genetic modification of donor animals is crucial for overcoming biological barriers.
• Recent advancements have focused on porcine models for xenotransplantation.

Purpose of the Study:

• To review recent genetic modifications in animals for xenotransplantation.
• To highlight strategies for overcoming xenogeneic barriers.
• To summarize efforts in reducing immune rejection and infectious risks.

Main Methods:

• Review of studies published in the last two years on genetically modified animals for xenotransplantation.
• Analysis of gene knockout strategies, specifically alpha1,3-galactosyltransferase.
• Examination of gene addition techniques to mitigate immune responses and viral transmission.

Main Results:

• Successful inactivation of the alpha1,3-galactosyltransferase gene in donor animals.
• Development of genetic modifications to reduce humoral and cellular immune responses.
• Strategies implemented to decrease complement activation, coagulation issues, and porcine endogenous retrovirus (PERV) transmission.

Conclusions:

• Genetic engineering is a pivotal tool in advancing xenotransplantation.
• Recent modifications effectively address key immunological and virological challenges.
• Further research in genetically modified animals holds promise for clinical xenotransplantation success.